Phase I/II Study Of Bavdegalutamide, A Protac Androgen Receptor (Ar) Degrader In Metastatic Castration-Resistant Prostate Cancer (Mcrpc): Radiographic Progression-Free Survival (Rpfs) In Patients (Pts) With Ar Ligand-Binding Domain (Lbd) Mutations
Bavdegalutamide
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Phase I/II Study Of Bavdegalutamide, A Protac Androgen Receptor (Ar) Degrader In Metastatic Castration-Resistant Prostate Cancer (Mcrpc): Radiographic Progression-Free Survival (Rpfs) In Patients (Pts) With Ar Ligand-Binding Domain (Lbd) Mutations ### Output: Bavdegalutamide